Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Hasler

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Frontiers in Neuroscience|April 9, 2015
The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studiesSylvia Terbeck, Funda Akkus, Laurence P Chesterman, et al.
Psychotherapy and Psychosomatics|April 16, 2014
The missing link between clinical states and biomarkers in mental disordersGiovanni A Fava, Jenny Guidi, Silvana Grandi, et al.
Frontiers in Psychiatry|May 21, 2020
Increased Anxiety After Stimulation of the Right Inferior Parietal Lobe and the Left Orbitofrontal CortexMatthias Grieder, Philipp Homan, Andrea Federspiel, et al.
Journal of Psychosomatic Research|July 17, 2004
Application of Prochaska's transtheoretical model of change to patients with eating disordersGregor Hasler, Aba Delsignore, Gabriella Milos, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 14, 2009
Impairments of probabilistic response reversal and passive avoidance following catecholamine depletionGregor Hasler, Krystal Mondillo, Wayne C Drevets, et al.
Psychoneuroendocrinology|January 22, 2013
Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptomsPhilipp Homan, Simona Grob, Gabriella Milos, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2023
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factorsPolina Ponomarenko, Federico Seragnoli, Abigail Calder, et al.
Clinical Drug Investigation|March 15, 2026
Effectiveness and Tolerability of Vortioxetine in Major Depressive Disorder: A Real-World Study in SwitzerlandMartin Kammerer, Gregor Hasler, Barbara Hochstrasser, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2023
Psychedelics in the treatment of eating disorders: Rationale and potential mechanismsAbigail Calder, Seline Mock, Nicole Friedli, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 16, 2017
Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapseStefanie Verena Mueller, Yoan Mihov, Andrea Federspiel, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Frontiers in Neuroscience|April 9, 2015
The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studiesSylvia Terbeck, Funda Akkus, Laurence P Chesterman, et al.
Psychotherapy and Psychosomatics|April 16, 2014
The missing link between clinical states and biomarkers in mental disordersGiovanni A Fava, Jenny Guidi, Silvana Grandi, et al.
Frontiers in Psychiatry|May 21, 2020
Increased Anxiety After Stimulation of the Right Inferior Parietal Lobe and the Left Orbitofrontal CortexMatthias Grieder, Philipp Homan, Andrea Federspiel, et al.
Journal of Psychosomatic Research|July 17, 2004
Application of Prochaska's transtheoretical model of change to patients with eating disordersGregor Hasler, Aba Delsignore, Gabriella Milos, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 14, 2009
Impairments of probabilistic response reversal and passive avoidance following catecholamine depletionGregor Hasler, Krystal Mondillo, Wayne C Drevets, et al.
Psychoneuroendocrinology|January 22, 2013
Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptomsPhilipp Homan, Simona Grob, Gabriella Milos, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2023
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factorsPolina Ponomarenko, Federico Seragnoli, Abigail Calder, et al.
Clinical Drug Investigation|March 15, 2026
Effectiveness and Tolerability of Vortioxetine in Major Depressive Disorder: A Real-World Study in SwitzerlandMartin Kammerer, Gregor Hasler, Barbara Hochstrasser, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2023
Psychedelics in the treatment of eating disorders: Rationale and potential mechanismsAbigail Calder, Seline Mock, Nicole Friedli, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 16, 2017
Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapseStefanie Verena Mueller, Yoan Mihov, Andrea Federspiel, et al.
Pageof 16